Yana Debie
Wilrijk, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
mRNA COVID-19 vaccines induce superior immunoglobulin A titers in patients with cancer compared with viral vector vaccines: implications for immunization strategies.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 27, 2025
Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.
Journal: Scientific reports
Published: September 23, 2024
Long-term effects of the COVID-19 pandemic for patients with cancer.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: June 20, 2024
Boosting capacity of a fourth dose BNT162b2 in cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 14, 2022
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Journal: Frontiers in immunology
Published: October 05, 2022
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 19, 2022
Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 17, 2021
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
Journal: ESMO open
Published: July 16, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026